Crinetics PharmaceuticalsCRNX
那斯達克 · USD
0
0
(0%)
盤中 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)
Crinetics PharmaceuticalsCRNX
0
0
(0%)
財務數據
損益表
- 0.01
- 0.00
- -
- -
- 0.00
- 0.01
- 0.00
- 0.06
- 0.11
- 0.25
- -
- -37.66
- -
- -
- -
- 185.60
- -86.13
- 4208.39
- 74.22
- 134.00
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 25,118 | 10,734 | 6,161 | 143 | 1,031 | 361 | - | - | 399 | 640 |
營業成本 | 154 | 200 | 1,076 | - | - | - | - | - | - | - |
營業毛利 | 24,964 | 10,534 | 5,085 | 143 | 1,031 | 361 | - | - | 399 | 640 |
營業費用 | 157,423 | 150,912 | 138,751 | 142,729 | 130,143 | - | 94,745 | - | 83,182 | - |
研發費用 | 99,850 | 100,081 | 85,053 | 90,464 | 80,301 | 76,240 | 66,566 | 61,905 | 58,344 | 53,341 |
推銷及管理費用 | 57,573 | 50,831 | 53,698 | 52,265 | 49,842 | 35,526 | 28,179 | 25,892 | 24,838 | 20,828 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -132,459 | -140,378 | -133,666 | -142,586 | -129,112 | -111,405 | -94,745 | -87,797 | -82,783 | -73,529 |
其他收入及費用 | 11,604 | 12,533 | 11,031 | 12,495 | 13,475 | 14,631 | 14,150 | 10,969 | 8,728 | 7,069 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -120,855 | -127,845 | -122,635 | -130,091 | -115,637 | -96,774 | -80,595 | -76,828 | -74,055 | -66,460 |
所得稅 | - | - | 180 | - | - | - | - | - | - | - |
稅後純益 | -120,855 | -127,845 | -122,815 | -130,091 | -115,637 | -96,774 | -80,595 | -76,828 | -74,055 | -66,930 |
基本每股稅後盈餘(元) | -1.14 | -1.23 | -1.29 | -1.38 | -1.23 | -1.04 | -0.88 | -0.96 | -0.94 | -0.93 |
稀釋每股稅後盈餘(元) | -1.14 | -1.23 | -1.29 | -1.39 | -1.23 | -1.04 | -0.87 | -0.96 | -0.93 | -0.93 |
基本平均股數(千股) | 105560.00 | 104099.00 | 95096.00 | 94215.00 | 93791.00 | 93102.00 | 91494.00 | 80091.00 | 79008.00 | 72289.00 |
稀釋平均股數(千股) | 105560.00 | 104099.00 | 95096.00 | 94215.00 | 93791.00 | 93102.00 | 91494.00 | 80091.00 | 79008.00 | 72289.00 |
還原基本每股稅後盈餘(元) | -1.14 | -1.23 | -1.29 | -1.38 | -1.23 | -1.04 | -0.88 | -0.96 | -0.94 | -0.93 |
還原稀釋每股稅後盈餘(元) | -1.14 | -1.23 | -1.29 | -1.39 | -1.23 | -1.04 | -0.87 | -0.96 | -0.93 | -0.93 |
還原基本平均股數(千股) | 105,560 | 104,099 | 95,096 | 94,215 | 93,791 | 93,102 | 91,494 | 80,091 | 79,008 | 72,289 |
還原稀釋平均股數(千股) | 105,560 | 104,099 | 95,096 | 94,215 | 93,791 | 93,102 | 91,494 | 80,091 | 79,008 | 72,289 |
EBITDA(千元) | -121,805 | -128,905 | -124,375 | -132,680 | -119,392 | -100,225 | -83,970 | -79,571 | -76,710 | -70,303 |